“The challenge today is how to communicate to the public to enhance the utilization of SERMs and reduce further the incidence of breast cancer,” he said.
Disclosures: The study was supported by the National Cancer Institute. Dr. Wickerham reported that he has consulted for Eli Lilly.
'These data are good news for postmenopausal women who want to reduce their risk of breast cancer.'
Source DR. WICKERHAM
'The challenge today is how to communicate to the public to enhance the utilization of SERMs.'
Source DR. HORTOBAGYI